Thermo Fisher Jan 6, 2026 Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes - Business Wire
Endpoints News Jan 6, 2026 Arrowhead’s RNAi obesity programs head to Phase 2 after encouraging early data
FierceBiotech Jan 6, 2026 FDA cites severe liver injury risk, unclear benefit behind Sanofi's MS drug rejection
FierceBiotech Jan 6, 2026 UK biotech eyes $1B deal to enable eye gene therapy to be delivered in doctors' offices
Thermo Fisher Jan 6, 2026 Robeco Institutional Asset Management B.V. Buys 233,200 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Agilent Jan 6, 2026 Evercore ISI Upgrades Agilent Technologies to Outperform From In Line, Adjusts PT to $160 From $155 - marketscreener.com
BEIJING LABTECH INSTRUMENTS CO.,LTD Jan 6, 2026 High Growth Tech Stocks in Asia to Watch January 2026 - Yahoo Finance
10x Genomics Blog Jan 6, 2026 10x Genomics Stock (+10%): Analyst Upgrades Spark a Short Cover Rally - Trefis
Illumina Jan 6, 2026 Why Illumina (ILMN) Is Up 6.5% After Advancing Grail Divestiture Plan And What's Next - Yahoo Finance
Illumina Jan 6, 2026 Why Illumina (ILMN) Is Up 6.5% After Advancing Grail Divestiture Plan And What's Next - Yahoo Finance UK
Thermo Fisher Jan 6, 2026 Thermo Fisher Scientific (NYSE:TMO) Sets New 52-Week High - Should You Buy? - MarketBeat